Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO

Diacerein is a symptomatic slow-acting drug in osteoarthritis (SYSADOA) with anti-inflammatory, anti-catabolic and pro-anabolic properties on cartilage and synovial membrane. It has also recently been shown to have protective effects against subchondral bone remodelling. Following the end of the rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavelka, Karel, Bruyère, Olivier, Cooper, Cyrus, Kanis, John A., Leeb, Burkhard F., Maheu, Emmanuel, Martel-Pelletier, Johanne, Monfort, Jordi, Pelletier, Jean-Pierre, Rizzoli, René, Reginster, Jean-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756045/
https://www.ncbi.nlm.nih.gov/pubmed/26849131
http://dx.doi.org/10.1007/s40266-016-0347-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756045/
https://www.ncbi.nlm.nih.gov/pubmed/26849131
http://dx.doi.org/10.1007/s40266-016-0347-4

Ejemplares similares